Josrik S 250mg/125mg Injection
Marketer
Joseph Lister Pharmaceuticals (P) Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Josrik S 250mg/125mg Injection
Sulfamethoxazole and Trimethoprim Injection (250mg/125mg), a dual-action antibiotic, combats a range of bacterial infections. This medication inhibits microbial proliferation, curbing infection spread. Administration must be under a doctor's guidance; strict adherence to the prescribed dosage schedule is vital. Completing the full course is crucial, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) necessitate prompt emergency care. Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Rest, proper nutrition, and hydration are key to recovery. Your physician may order lab tests to monitor the medicine's effects.
Uses of Josrik S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Josrik S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Josrik S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Josrik S 250mg/125mg Injection:
This medication will be administered by your physician or their qualified nurse. Self-medication is strictly prohibited.
How Josrik S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam (Josrik S 250mg/125mg Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism of action involves disrupting bacterial cell wall synthesis, a process vital for bacterial survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thus bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Josrik S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Josrik S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Josrik S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Josrik S 250mg/125mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Josrik S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Josrik S 250mg/125mg requires careful administration in individuals with severe hepatic impairment, potentially necessitating dosage modification. Physician consultation is advised. Dosage alteration for Josrik S 250mg/125mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Josrik S 250mg/125mg Injection :
Should you forget a dose of Josrik S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Josrik S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently